Inovio Pharmaceuticals logo

Inovio Pharmaceuticals

North America, Pennsylvania, United States, Plymouth Meeting

Description

Inovio is a biotech company focusing on bringing to market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.

Investor Profile

Inovio Pharmaceuticals has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Oncology
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Inovio Pharmaceuticals frequently co-invest with?

Sante Ventures
North America, Texas, United States, Austin
Co-Investments: 3
Global Bio Fund
Oceania, Auckland, New Zealand, Auckland
Co-Investments: 1
Korea Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Flerie Invest
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1

What are some of recent deals done by Inovio Pharmaceuticals?

Geneos Therapeutics

Plymouth Meeting, Pennsylvania, United States

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

BiotechnologyHealth CareOncologyPharmaceuticalTherapeutics
Series AMar 24, 2022
Amount Raised: $17,000,000
Geneos Therapeutics

Plymouth Meeting, Pennsylvania, United States

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

BiotechnologyHealth CareOncologyPharmaceuticalTherapeutics
Series AMar 3, 2021
Amount Raised: $12,000,000
Geneos Therapeutics

Plymouth Meeting, Pennsylvania, United States

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

BiotechnologyHealth CareOncologyPharmaceuticalTherapeutics
Series AFeb 21, 2019
Amount Raised: $10,500,000